Login to Your Account



Financings Roundup


Monday, January 14, 2013
• Aegerion Pharmaceuticals Inc., of Cambridge, Mass., priced a public offering of about 2.7 million shares of stock at Thursday's closing price of $26.64 per share, with net proceeds to total about $67.9 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription